Search for: "C Campbell" Results 81 - 100 of 1,282
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Jan 2024, 12:44 pm by Bergeson & Campbell, P.C.
(B&C®) and its global consulting affiliate The Acta Group (Acta®) and consortia management affiliate B&C® Consortia Management, L.L.C. [read post]
5 Jan 2024, 9:00 am by Bergeson & Campbell, P.C.
(B&C®) and its global consulting affiliate The Acta Group (Acta®) and consortia management affiliate B&C® Consortia Management, L.L.C. [read post]
5 Jan 2024, 9:00 am by Bergeson & Campbell, P.C.
(B&C®) and its global consulting affiliate The Acta Group (Acta®) and consortia management affiliate B&C® Consortia Management, L.L.C. [read post]
3 Jan 2024, 1:47 pm by Bergeson & Campbell, P.C.
(B&C®) and its global consulting affiliate The Acta Group (Acta®) and consortia management affiliate B&C® Consortia Management, L.L.C. [read post]
3 Jan 2024, 1:47 pm by Bergeson & Campbell, P.C.
(B&C®) and its global consulting affiliate The Acta Group (Acta®) and consortia management affiliate B&C® Consortia Management, L.L.C. [read post]
14 Dec 2023, 8:56 am by Bergeson & Campbell, P.C.
Meibao Zhuang, Senior Scientist/Regulatory Consultant with B&C and our consulting affiliate, The Acta Group, to discuss double-stranded ribonucleic acid interference, better known as ds RNAi. [read post]
14 Dec 2023, 8:56 am by Bergeson & Campbell, P.C.
Meibao Zhuang, Senior Scientist/Regulatory Consultant with B&C and our consulting affiliate, The Acta Group, to discuss double-stranded ribonucleic acid interference, better known as ds RNAi. [read post]